TNYA – tenaya therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Tenaya Therapeutics, Inc. (NASDAQ: TNYA) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $18.00 to $16.00. They now have a "buy" rating on the stock.
Tenaya Therapeutics, Inc. (NASDAQ: TNYA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
Tenaya Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
Tenaya Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
Gladstone's Deepak Srivastava Honored as Most Admired CEO by San Francisco Business Times [Yahoo! Finance]
Form 10-Q Tenaya Therapeutics, For: Mar 31
Form 8-K Tenaya Therapeutics, For: May 13
Form ARS Tenaya Therapeutics, For: Dec 31
Form DEFA14A Tenaya Therapeutics,
Form DEF 14A Tenaya Therapeutics, For: May 30
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.